2020 (1 POST)
Suh M , Verwiel A , Proctor D . Oral and inhalation bioaccessibility of cobalt and nickel in metal alloys: A critical consideration for site-specific human health risk assessments and read across. Poster for Society of Toxicology 59th Annual Meeting, Virtual, 2020.
View Abstract
Publication: Abstracts and Presentations
2017 (1 POST)
Fung ES, Monnot AD, Tvermoes BE, Unice KM, Kovochich M, Galbraith DA, Finley BL , Paustenbach DJ. Characteristics of cobalt related cardiomyopathy in metal hip implant patients. Abstract #2142. Poster presentation at Society of Toxicology 56th Annual Meeting, Baltimore, MD, 2017.
Publication: Abstracts and Presentations
2016 (2 POSTS)
Suh M , Thompson CM , Brorby GP , Mittal L , Proctor DM . 2016. Inhalation cancer risk assessment of cobalt metal. Regul Toxicol Pharm 79(Aug):74-82; doi: 10.1016/j.yrtph.2016.05.009 .
View Abstract
Publication: Manuscripts
Brorby GP , Suh M , Thompson CM , Mittal L , Proctor DM . Inhalation cancer risk assessment of cobalt metal. Presented at Society of Toxicology 55th Annual Meeting, New Orleans, LA, March 2016.
View Abstract
Publication: Abstracts and Presentations
2015 (2 POSTS)
Madl AK, Kovochich M, Liong M, Finley BL , Paustenbach DJ, Oberdorster G. 2015. Toxicology of wear particles of cobalt-chromium alloy metal-on-metal hip implants Part II: Importance of physiochemical properties and dose in animal and in vitro studies as a basis for risk assessment. Nanomed: Nanotech Biol Med 11(5):1285–1298; doi: 10.1016/j.nano.2015.02.006 . PMID: 25735266.
View Abstract
Publication: Manuscripts
Christian WV, Oliver LD, Paustenbach DJ, Kreider ML, Finley BL . Toxicology based cancer causation analysis of COCR-containing hip implants: A quantitative assessment of genotoxicity and tumorigenicity studies. Poster presentation at Society of Toxicology 54th Annual Meeting, San Diego, CA, 2015.
Publication: Abstracts and Presentations
2014 (3 POSTS)
Paustenbach DJ, Galbraith DA, Finley BL . 2014. Interpreting cobalt blood concentrations in hip implant patients. Clin Toxicol 52(2):98–112; doi: 10.3109/15563650.2013.857024 . PMID: 24256093.
View Abstract
Publication: Manuscripts
Unice KM, Kerger BD, Paustenbach DJ, Finley BL , Tvermoes BE. 2014. Refined biokinetic model for humans exposed to cobalt dietary supplements and other sources of systemic cobalt exposure. Chem-Biol Interact 216:53–74; doi: 10.1016/j.cbi.2014.04.001 . PMID: 24726710.
View Abstract
Publication: Manuscripts
Tvermoes BE, Unice KM, Paustenbach DJ, Finley BL , Otani JM, Galbraith DA. 2014. Effects and blood concentrations of cobalt after ingestion of 1 mg/d by human volunteers for 90 d1-3. Am J Clin Nutr 99(3):632–646, doi: 10.3945/ajcn.113.071449 . PMID: 24500148.
Publication: Manuscripts
2013 (5 POSTS)
Tvermoes BE, Finley BL , Unice KM, Otani JM, Paustenbach DJ, Galbraith DA. 2013. Cobalt whole blood concentrations in healthy adult male volunteers following two-weeks of ingesting a cobalt supplement. Food Chem Toxicol 53:432–439; doi: 10.1016/j.fct.2012.11.033 . PMID: 23207477.
View Abstract
Publication: Manuscripts
Paustenbach DJ, Tvermoes BE, Unice KM, Finley BL , Kerger BD. 2013. A review of the health hazards posed by cobalt. Crit Rev Toxicol 43(4):316–362; doi:10.3109/10408444.2013.779633 . PMID: 23656559.
View Abstract
Publication: Manuscripts
Kerger BD, Tvermoes BE, Unice KM, Finley BL , Paustenbach DJ, Galbraith DA. 2013. Cobalt speciation assay for human serum, Part II. Method validation in a study of human volunteers ingesting cobalt (II) chloride dietary supplement for 90 days. Toxicol Environ Chem 95(4):709–718; doi: 10.1080/02772248.2013.792559 .
View Abstract
Publication: Manuscripts
Kerger BD, Gerads R, Gurleyuk H, Thuett KA, Finley BL , Paustenbach DJ. 2013. Cobalt speciation assay for human serum, Part I. Method for measuring large and small molecular cobalt and protein-binding capacity using size exclusion chromatography with inductively-coupled plasma-mass spectroscopy detection. Toxicol Environ Chem 95(4):687–708; doi: 10.1080/02772248.2013.793444 .
View Abstract
Publication: Manuscripts
Finley BL , Unice KM, Kerger BD, Otani JM, Paustenbach DJ, Galbraith DA, Tvermoes BE. 2013. 31-day study of cobalt (II) chloride ingestion in humans: Pharmacokinetics and clinical effects. J Toxicol Environ Health A, 76:1210–1224; doi: 10.1080/15287394.2013.848391 . PMID: 24283372.
Publication: Manuscripts
2012 (3 POSTS)
Unice KM, Monnot AD, Gaffney SH, Tvermoes BE, Thuett KA, Paustenbach DJ, Finley BL . 2012. Inorganic cobalt supplementation: Prediction of cobalt levels in whole blood and urine using a biokinetic model. Food Chem Toxicol 50(7):2456–2461; doi: 10.106/j.fct.2012.04.009 . PMID: 22538081.
View Abstract
Publication: Manuscripts
Finley BL , Monnot AD, Gaffney SH, Paustenbach DJ. 2012. Dose-response relationships for blood cobalt concentrations and health effects: A review of the literature and application of a biokinetic model. J Toxicol Environ Health B, 15(8):493–523; doi: 10.1080/10937404.2012.744287 .
View Abstract